About: High-Altitude Pulmonary Edema

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: High-Altitude Pulmonary Edema Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	High-Altitude Pulmonary Edema
Creator	Swenson, Erik
Source	PMC
abstract	High-altitude pulmonary edema (HAPE) is an uncommon form of pulmonary edema that occurs in healthy individuals within a few days of arrival at altitudes above 2,500–3,000 m. The crucial pathophysiology is an excessive hypoxia-mediated rise in pulmonary vascular resistance (PVR) or hypoxic pulmonary vasoconstriction (HPV) leading to increased microvascular hydrostatic pressures despite normal left atrial pressure. The resultant hydrostatic stress can cause both dynamic changes in the permeability of the alveolar capillary barrier and mechanical damage leading to leakage of large proteins and erythrocytes into the alveolar space in the absence of inflammation. Bronchoalveolar lavage (BAL) and pulmonary artery (PA) and microvascular pressure measurements in humans confirm that high capillary pressure induces a high-permeability non-inflammatory-type lung edema; a concept termed “capillary stress failure.” Measurements of endothelin and nitric oxide (NO) in exhaled air, NO metabolites in BAL fluid, and NO-dependent endothelial function in the systemic circulation all point to reduced NO availability and increased endothelin in hypoxia as a major cause of the excessive hypoxic PA pressure rise in HAPE-susceptible individuals. Other hypoxia-dependent differences in ventilatory control, sympathetic nervous system activation, endothelial function, and alveolar epithelial sodium and water reabsorption likely contribute additionally to the phenotype of HAPE susceptibility. Recent studies using magnetic resonance imaging in humans strongly suggest nonuniform regional hypoxic arteriolar vasoconstriction as an explanation for how HPV occurring predominantly at the arteriolar level can cause leakage. This compelling but not yet fully proven mechanism predicts that in areas of high blood flow due to lesser vasoconstriction edema will develop owing to pressures that exceed the structural and dynamic capacity of the alveolar capillary barrier to maintain normal alveolar fluid balance. Numerous strategies aimed at lowering HPV and possibly enhancing active alveolar fluid reabsorption are effective in preventing and treating HAPE. Much has been learned about HAPE in the past four decades such that what was once a mysterious alpine malady is now a well-characterized and preventable lung disease. This chapter will relate the history, pathophysiology, and treatment of HAPE, using it not only to illuminate the condition, but also for the broader lessons it offers in understanding pulmonary vascular regulation and lung fluid balance.
has issue date	2010-06-28(xsd:dateTime)
bibo:doi	10.1007/978-0-387-87429-6_61
has license	no-cc
sha1sum (hex)	02160d77412b8d730f1c5338b62e88b492a10708
schema:url	https://doi.org/10.1007/978-0-387-87429-6_61
resource representing a document's title	High-Altitude Pulmonary Edema
has PubMed Central identifier	PMC7122766
schema:publication	Textbook of Pulmonary Vascular Disease
resource representing a document's body	covid:02160d77412b8d730f1c5338b62e88b492a10708#body_text
is schema:about of	named entity 'space' named entity 'humans' named entity 'endothelin' named entity 'fluid balance' named entity 'proteins' named entity 'reduced' named entity 'vascular' named entity 'condition' named entity 'studies' named entity 'Recent' named entity 'PVR' named entity 'HPV' named entity 'atrial' named entity 'develop' named entity 'alveolar' named entity 'magnetic resonance imaging' named entity 'induces' named entity 'strategies' named entity 'exceed' named entity 'individuals' named entity 'regional' named entity 'hypoxic' named entity 'arteriolar' named entity 'hydrostatic pressures' named entity 'systemic circulation' named entity 'blood flow' named entity 'capillary' named entity 'HAPE' named entity 'erythrocytes' named entity 'HAPE' named entity 'metabolites' named entity 'hypoxia' named entity 'permeability' named entity 'nitric oxide' named entity 'hypoxic pulmonary vasoconstriction' named entity 'capillary' named entity 'edema' named entity 'altitudes' named entity 'hemodynamics' named entity 'blood flow' named entity 'causal factor' named entity 'wedge pressure' named entity 'COPD' named entity 'ENaC' named entity 'PPH' named entity 'sodium' named entity 'HPV' named entity 'endothelium' named entity 'IL-6' named entity 'viral infections' named entity 'fluid accumulation' named entity 'pulmonary hypertension' named entity 'diastolic' named entity 'inflammation' named entity 'nitric oxide' named entity 'FRC' named entity 'Nifedipine' named entity 'HAPE' named entity 'lymph' named entity 'sodium' named entity 'HAPE' named entity 'hydrostatic pressures' named entity 'Bronchoalveolar lavage' named entity 'extracellular matrix proteins' named entity 'permeability' named entity 'ENaC' named entity 'Autopsies' named entity 'infection' named entity 'permeability' named entity 'control group' named entity 'capillaries' named entity 'metabolites' named entity 'chest radiography' named entity 'endotoxin' named entity 'bioactive' named entity 'epithelial' named entity 'mmHg' named entity 'TLC' named entity 'nitrite' named entity 'sodium' named entity 'nitric oxide' named entity 'HAPE' named entity 'nitric oxide'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software